Iressa AstraZeneca - Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)

Iressa is indicated as a monotherapy for the treatment of patients with locally advanced or metastatic NSCLC after failure of both platinum-based and docetaxel chemotherapies.

Posted: May 2003

View comments

Hide
(web1)